Physician profile
Duc Le
NPI 1952313462
$4,595.66
in general payments reported to CMS, 2019-2025
34 companies · $478 in 2025
The $478 reported for 2025 was more than what 78% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $890 · 2020: $202 · 2021: $854 · 2022: $569 · 2023: $869 · 2024: $733 · 2025: $478.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,081.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,080.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $840.73 | 2019-2025 | |
| Abbvie INC. | $786.99 | 2019-2024 | |
| Caldera Medical, INC | $489.04 | 2023-2024 | Desara |
| Mayne Pharma Commercial LLC | $389.63 | 2021-2025 | |
| Astellas Pharma US INC | $270.27 | 2022-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $210.97 | 2023-2025 | Myfembree |
| Exact Sciences Corporation | $169.96 | 2023-2025 | Cologuard Collection Kit |
| Olympus America INC. | $148.48 | 2019 | |
| Lupin INC. | $132.00 | 2019-2021 | |
| Shield Therapeutics INC | $128.01 | 2022-2024 | Accrufer |
| Myovant Sciences INC. | $125.75 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $121.65 | 2019-2025 | |
| Pfizer INC. | $100.84 | 2022-2024 | |
| Exeltis, USA INC. | $81.77 | 2024 | Slynd |
| Hologic Sales and Service, LLC | $70.17 | 2019-2025 | Thinprep 2000 Processor, Aptima, Affirm Prone Biopsy System |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $67.54 | 2022-2024 | Twirla |
| Smith+Nephew, INC. | $59.90 | 2021-2023 | Stravix Pl |
| Millicent US INC | $42.36 | 2025 | Femlyv |
| Therapeuticsmd, INC. | $33.86 | 2019 | |
| Allergan, INC. | $32.79 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $31.44 | 2019 | |
| Avion Pharmaceuticals | $29.98 | 2021 | |
| Ethicon US, LLC | $27.41 | 2019 | |
| Gynesonics, INC. | $24.20 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Sage Therapeutics, LLC | $22.19 | 2024 | |
| Organon LLC | $19.92 | 2022 | |
| Mylan Pharmaceuticals INC. | $19.81 | 2022 | |
| Mycovia Pharmaceuticals, INC. | $19.39 | 2023 | Vivjoa |
| Merck Sharp & Dohme LLC | $18.99 | 2019 | |
| Dexcom, INC. | $18.54 | 2025 | Dexcom G6 Transmitter |
| Evofem Biosciences, INC. | $18.32 | 2022 | |
| Amgen INC. | $17.66 | 2019 | |
| Acessa Health INC. | $12.71 | 2019 | |
| Coopersurgical, INC. | $12.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Duc Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.